NATAN D. KAHN, MD

Plain English
This study looked at osteoprotegerin (OPG), a protein that may indicate how severe pulmonary fibrosis is, particularly idiopathic pulmonary fibrosis (IPF). Researchers found that OPG levels were much higher in the lung tissues of patients with fibrosis compared to healthy controls, with levels over 1,243 pg/mL indicating disease progression. This matters because measuring OPG could help doctors assess how fast the disease is worsening in patients, allowing for better treatment planning. Who this helps: This helps patients with pulmonary fibrosis and their doctors.

Plain English
This study looked at patients with pneumonia caused by COVID-19 and other types of pneumonia in hospitals in Córdoba, Argentina, between March 2020 and October 2021. The researchers found that COVID-19 pneumonia affected younger men more often and was more likely to become severe compared to other types of pneumonia; 61.5% of COVID-19 cases were severe, while 49.2% of non-COVID pneumonia cases were severe. Understanding these differences is important for doctors to make better treatment decisions and improve patient outcomes. Who this helps: This helps doctors and healthcare providers in managing pneumonia patients effectively.

Plain English
This research paper looks at the use of blood pressure kiosks in public spaces, which allow people to check their own blood pressure without professional help. After reviewing 54 studies, the authors found that these kiosks measure blood pressure very similarly to traditional office measurements, with a difference of less than 1 mmHg for systolic and diastolic readings. However, the accuracy compared to home and daytime measurements was less reliable, with differences as high as 8.1 mmHg. This is important because it highlights both the potential benefits of kiosk blood pressure checks for early detection of hypertension and the need for better validation and standards for their use. Who this helps: This helps patients and healthcare providers by providing a convenient way to monitor blood pressure in public, potentially leading to earlier hypertension diagnosis and management.

Plain English
This research highlights the growing need for anesthesiologists in interventional radiology (IR), where complex and high-risk medical procedures are increasingly common. Studies show that having an anesthesiologist present leads to fewer procedural risks, improved patient satisfaction, and faster recovery times. Despite these clear benefits, many IR teams lack enough anesthetic support, which is crucial for ensuring patient safety and effective procedures. Who this helps: Patients undergoing interventional radiology procedures benefit most from increased anesthetic support.

Plain English
This study looked at a serious injury to the trachea (the windpipe) in a 51-year-old woman who had a large tear after surgery. The doctors found that using a special technique called venovenous extracorporeal membrane oxygenation (V-V ECMO) helped her breathe better and allowed the injury to heal completely. This is important because it shows that ECMO can be a crucial treatment option for patients with severe tracheal injuries, especially when traditional methods aren't enough. Who this helps: This helps patients with serious tracheal injuries and their doctors.

Plain English
This study looks at how adding a treatment called chronotherapy to standard care can help people with depression feel better more quickly. Involving 76 participants, the research will compare those who receive standard treatment plus chronotherapy to those who only receive standard treatment. The researchers will measure changes in depression symptoms, quality of life, and sleep over time, particularly focusing on the first week to see if chronotherapy makes a significant difference. Who this helps: This benefits patients suffering from depression by potentially speeding up their recovery process.

Plain English
The study looked at how a treatment called flow diversion affects blood flow in brain aneurysms using advanced imaging technology. Researchers found that after treatment, blood flow inside the aneurysms decreased significantly, with a flow ratio dropping to about 64% of its original value, while flow in the nearby blood vessels remained stable. This information is crucial because it helps doctors understand the effectiveness of flow diversion treatments, which can ultimately improve patient outcomes. Who this helps: This helps patients with brain aneurysms and their doctors.

Plain English
This study looked at the quality of information about sarcoidosis available on YouTube videos aimed at patients. Out of 85 videos analyzed, most came from academic or government sources, but these videos still provided incomplete information, scoring an average of 10.5 out of 25 on content quality. This matters because many patients rely on YouTube for health information, but they often get incomplete or misleading details, particularly about important topics like disease progression and screening for symptoms outside the lungs. Who this helps: This helps patients and caregivers looking for reliable information on sarcoidosis.

Plain English
The study looked at how many primary care doctors in an Appalachian medical center refuse to provide medical care, specifically gender-affirming hormone therapy, to transgender and gender-diverse (TGD) patients. Out of 115 surveyed doctors, 23.5% did not want to prescribe hormone therapy to adults and 33% objected for minors, especially among those who identified as "very religious." This is important because these objections can make it harder for TGD individuals to get the care they need in a region where medical resources are already limited. Who this helps: TGD patients seeking hormone therapy in rural areas.

Plain English
This study looked at lung cancer in patients with idiopathic pulmonary fibrosis (IPF) across seven European countries. They found that 10.2% of IPF patients developed lung cancer, and after ten years, 26.6% of those alive were diagnosed with it. Patients with both conditions faced a higher risk of dying, particularly those with higher monocyte counts, while those treated with antifibrotics or surgically tended to have better outcomes. Who this helps: This research benefits patients with IPF and lung cancer, as well as the doctors treating them.

Plain English
This study looked at how bronchial cells from patients with idiopathic pulmonary fibrosis (IPF) respond to different treatments, including two existing drugs (pirfenidone and nintedanib) and a new drug (saracatinib). The research found that IPF patients respond differently to these treatments based on their individual cell conditions. Specifically, saracatinib showed a significant effect by lowering the levels of inflammation markers and certain genes associated with fibrotic disease more effectively than traditional drugs. Who this helps: This information benefits patients with IPF by pointing towards more personalized treatment options.

Plain English
This study explored how effective digital cognitive behavior therapy (CBT) for insomnia is for people also experiencing chronic fatigue. Researchers analyzed data from 1,717 participants and found that those with chronic fatigue showed significant improvements in their insomnia symptoms, mental health, and levels of anxiety and depression after receiving the therapy compared to those who only received patient education. Specifically, the insomnia severity improved notably, with a strong effect size of 1.36, indicating that the therapy is effective regardless of the presence of chronic fatigue. Who this helps: This benefits patients dealing with insomnia along with chronic fatigue.

Plain English
This study looked at how certain types of particle interactions, called Feshbach resonances, work when molecular hydrogen ions collide with noble gas atoms at very cold temperatures. The researchers discovered specific patterns in these collisions, revealing that Feshbach resonances can show different behaviors depending on the distance between the particles. This finding is important because it helps scientists better understand the underlying physics of atomic interactions, which can improve future experiments and applications in fields like quantum computing and chemistry. Who this helps: This helps scientists and researchers working with cold atoms and molecules.

Plain English
This study looked at how well German patients with pulmonary sarcoidosis understand their disease. It found that while 59.4% of patients felt well informed, 40.6% felt they were lacking important information, especially about their future outlook and issues like fatigue and pain. Most of the information came from their doctors or the internet, but there is still a significant need for better education and support. Who this helps: This helps patients with sarcoidosis by identifying their information needs and guiding healthcare providers on how to better support them.

Plain English
This study looked at the quality and content of information about sarcoidosis available on the internet. Researchers examined the first 200 search results from popular search engines and found that while many sites are scientific or governmental, the quality of the information was only partially sufficient; for example, the average quality score was just 2 out of 4 on one measurement scale. This matters because many patients rely on online information for understanding their condition, yet important aspects of sarcoidosis are often overlooked and the information may not be accurate or comprehensive. Who this helps: This benefits patients and their families seeking reliable information about sarcoidosis.

Plain English
This study looked at the experiences of transgender and gender-diverse adolescents and their caregivers when seeking gender-affirming care in primary care settings. Out of 33 participants, many faced challenges like negative experiences with healthcare providers but also recognized the convenience of receiving care from their trusted primary care doctors. The findings emphasize the need for better training and resources for primary care providers to improve care for TGD youth. Who this helps: This benefits transgender and gender-diverse adolescents and their caregivers seeking affirming healthcare.

Plain English
In this study, researchers tested a new combination therapy for a patient with a recurring type of brain cancer called leptomeningeal glioblastoma. They found that by using a mix of five drugs—lomustine, olaparib, digoxin, metformin, and high doses of vitamin C—they were able to effectively target the specific weaknesses in the cancer, leading to significant improvement in the patient's condition. This approach may offer a new strategy for treating aggressive brain tumors that are hard to manage. Who this helps: This benefits patients with advanced brain cancer.

Plain English
This study looked at a new imaging technique called FAPI PET/CT to better understand fibrotic interstitial lung diseases (fILD) and lung cancer (LC). Researchers found that fILD lesions showed a high uptake of the FAPI tracer, with an average uptake value of 11.12, while lung cancer lesions had an even higher average value of 16.69, indicating that this imaging method can effectively highlight areas of lung fibrosis and cancer. This is important as it could help doctors better monitor the progression of these diseases and evaluate treatments in the future. Who this helps: This benefits patients with fibrotic lung diseases and lung cancer, as well as their healthcare providers.

Plain English
The study looked at YouTube videos about lymphangioleiomyomatosis (LAM) to see how good the health information was for patients. Out of 64 videos, most had low quality ratings, with only 10% being reliable. This matters because patients need trustworthy and accurate information about LAM, and the majority of available videos do not meet those needs. Who this helps: Patients with lymphangioleiomyomatosis.

Plain English
This study focused on creating a new type of tissue that mimics lung tumors to help improve tools used in a procedure called radiofrequency ablation (RFA), which treats these tumors. Researchers found that this new tissue could be adjusted to match the electrical properties of real lung tumors, making it easier to see the edges of the area being treated. Specifically, the average electrical resistance in actual lung tumors was 103.5 ohms, while the new tissue could be tailored to reach values between 74.3 and 183.2 ohms, depending on how much salt was added. Who this helps: This benefits doctors and researchers developing RFA techniques, as well as patients needing treatment for lung tumors.

Plain English
This study looked at how changing the chemical structure of a specific organic semiconductor affects its behavior when temperatures change. Researchers found that these changes can reduce certain unwanted vibrations in the material, which helps it maintain its useful properties. Notably, different modified versions of the semiconductor showed improvements, with the most effective being the ones with specific structural changes, leading to fewer disruptions as temperatures fluctuate. Who this helps: This helps researchers and manufacturers working with organic semiconductors in electronics.

Plain English
This study looked at how a protein called TGF-β1 affects lung cells in a disease known as idiopathic pulmonary fibrosis (IPF). Researchers found that when TGF-β1 is activated, it triggers a series of reactions that produce harmful substances in the cells, leading to DNA damage and increased levels of genes that promote lung scarring. Specifically, they found that a specific signaling pathway involving the protein FYN and another protein called NOX4 plays a significant role in this process, which is linked to the severity of IPF in patients. Who this helps: This research helps patients with idiopathic pulmonary fibrosis by improving our understanding of the disease's mechanisms, potentially leading to new treatments.

Plain English
This study looked at the distribution of oxygen vacancies in a material called yttrium-doped ceria, which is important for certain electronic applications. Researchers found that using a special technique, they could enhance the sensitivity of their observations and discovered that the yttrium atoms did not cluster together in areas with many oxygen vacancies. This matters because understanding how these vacancies are distributed can help improve the design of materials that conduct oxygen ions, which are used in various technological applications. Who this helps: This helps scientists and engineers working on advanced materials for energy and electronic devices.

Plain English
This study investigated the drug pirfenidone, which is known to slow disease progression in a specific lung disease, to see if it could also help patients with other types of lung diseases that cause scarring, known as progressive fibrotic interstitial lung diseases (ILDs). In a trial with 127 patients, those on pirfenidone experienced a smaller decline in lung function compared to those on a placebo, with an estimated difference of about 3.5% in their lung capacity after 48 weeks. This finding is significant as it offers a potential new treatment option for patients suffering from these challenging conditions. Who this helps: This helps patients with progressive fibrotic interstitial lung diseases.

Plain English
This study explored a new method called "freeze-spot" for applying a chemical matrix before imaging samples using mass spectrometry, a technique that helps visualize where different molecules are located in a biological sample. The researchers found that this method uses less material, is quick to apply, and maintains the clarity of the images produced—allowing for better detection of small samples. This matters because it improves the effectiveness and cost-efficiency of metabolite analysis, which is crucial in researching diseases and potential treatments. Who this helps: This benefits researchers studying diseases and developing new treatments.

Plain English
This study looked at the costs of medication needed to treat different types of interstitial lung disease (ILD), specifically focusing on idiopathic pulmonary fibrosis (IPF) and other ILDs. It found that, on average, the medication costs for patients with IPF rose dramatically from €1,442 to €11,000 over three years, while costs for other ILDs remained much lower, ranging from €487 to €9,142. This matters because the high costs of treating IPF place a significant financial strain on the healthcare system, and improving treatment strategies could help ease this burden. Who this helps: This benefits patients with ILD, their families, and healthcare providers.

Plain English
This study looked at acute exacerbations (sudden worsening of symptoms) in patients with idiopathic pulmonary fibrosis (IPF), a serious lung disease. It found that these exacerbations lead to high in-hospital death rates and poor outcomes for patients. Currently, treatment usually involves high doses of steroids and antibiotics, but there are no specific guidelines to manage these crises effectively, highlighting the need for more research into better care options. Who this helps: This information benefits patients with IPF and their doctors.

Plain English
Researchers examined how different definitions of a severe type of lung disease known as fibrosing interstitial lung disease (fILD) affect patient classification and outcomes. They looked at data from 566 patients and found that different definitions labeled varying percentages of patients as having a more aggressive form of the disease: 41% with one definition, 32% with another, and nearly 50% with the broadest criteria. The differences in definitions can lead to significant impacts on treatment plans and patient care, as those labeled with a more aggressive disease may have worse health outcomes. Who this helps: This research benefits doctors and healthcare providers by providing clearer insights into patient classifications for better treatment decisions.

Plain English
This study looked at how a medication called nintedanib is being used to treat idiopathic pulmonary fibrosis (IPF) and other lung diseases. Researchers found that nintedanib has been effective in improving treatment guidelines and managing the disease better, especially for patients with advanced lung issues or those undergoing lung transplants. Progress in this area is crucial because it can lead to better health outcomes for patients suffering from these serious lung conditions. Who this helps: This helps patients with idiopathic pulmonary fibrosis and similar lung diseases.

Plain English
This study compared six different questionnaires designed to help diagnose interstitial lung diseases (ILD), which are complex and varied conditions affecting the lungs. The researchers found that these questionnaires varied in length and detail; for example, the UCLA questionnaire focuses heavily on connective tissue diseases, while the National Jewish Health questionnaire provides thorough capture of past diagnostic tests. Developing a standardized questionnaire that doctors can use worldwide will improve how these diseases are diagnosed and treated. Who this helps: This helps patients with interstitial lung diseases by ensuring they receive better and more accurate diagnoses.

Plain English
This study looked at how well patients with idiopathic pulmonary fibrosis (IPF) survive and how their lung function changes when they receive antifibrotic treatment compared to those who do not. Researchers followed 588 patients for an average of 1.2 years and found that those on antifibrotic therapy had a 37% lower risk of death; the 1-year survival rate was 87% for those treated and 62% for those not treated. While survival improved with treatment, lung function measurements remained similar for both groups, meaning that patients might still face premature death even with stable lung function. Who this helps: This research benefits patients with IPF and their doctors by highlighting the importance of antifibrotic treatments in improving survival.

Plain English
This research paper focuses on idiopathic pulmonary fibrosis (IPF), a serious lung disease that causes permanent scarring of the lungs. The study found that while progress has been made in understanding the disease and treating it with new medications, diagnosing IPF still requires a team of specialists to ensure accuracy. Antifibrotic drugs have changed how we treat IPF, and it's important to also use non-drug therapies to help patients feel better and improve their overall well-being. Who this helps: Patients with idiopathic pulmonary fibrosis.

Plain English
This study looked at how the quality of life for patients with interstitial lung disease (ILD) changes over a year. Researchers found that about one in three patients experienced a significant decline in their quality of life, especially those with lower lung function at the start. Specifically, 30% of patients reported worse symptoms and overall health, highlighting the need for better management of lung function to help maintain a better quality of life. Who this helps: Patients with interstitial lung disease.

Plain English
This study looked at different types of stem cells found in fat tissue that can develop into either bone or fat cells. Researchers discovered a specific protein called CD107a on the surface of these stem cells that helps distinguish between two groups: those that can create bone and those that mostly turn into fat cells. They found that stem cells with CD107a can form more bone and do so effectively in living animals, indicating their potential for treating bone-related conditions. Who this helps: This helps patients needing bone repair or treatment, such as those with osteoporosis or fractures.

Plain English
This study looked at a program where experienced parents provide support to other families with children facing mental health challenges. Researchers found that using a tool called the Family Journey Assessment (FJA) showed significant improvements in families' abilities to recognize their needs, collaborate for help, and develop coping skills, with 436 assessments indicating clear progress. This matters because it helps ensure that families receive the right support, enhancing their ability to navigate stress and care for their children effectively. Who this helps: This benefits families of children with mental health challenges and the support providers working with them.

Plain English
This research paper discusses a partnership between the government and continuing education groups to tackle the opioid crisis, which was declared a public health emergency due to a staggering 116 opioid-related deaths every day in 2016. The collaboration involved a wide range of health professionals working together to create mandatory training for prescribers, helping them understand the risks of opioids. This effort is important because better-prescribing practices can lead to fewer overdoses and better management of pain. Who this helps: This benefits doctors and healthcare providers by giving them the knowledge they need to prescribe opioids safely.

Plain English
This article summarizes important discoveries and updates discussed at the 2018 European Respiratory Society Congress in Paris, focusing on issues related to lung health. Key findings include advancements in managing chronic lung diseases, new techniques for imaging the lungs, and improvements in patient care practices. These developments are crucial because they can lead to better treatments and support for patients with respiratory conditions. Who this helps: Patients with chronic lung diseases and their caregivers.

Plain English
This study examined how the quality of life (QoL) changes over time for people with idiopathic pulmonary fibrosis (IPF) using data from 424 patients in Germany. It found that QoL significantly worsened, with scores increasing by 1.47 points each year on a specific QoL questionnaire, indicating declining health. Additionally, patients who experienced a significant drop in lung function showed even greater declines in their QoL scores, especially those who were hospitalized or died. Who this helps: This research helps patients with IPF and their doctors by highlighting the relationship between lung function and quality of life, guiding treatment decisions.

Plain English
This study looked at how different pediatric surgeons and urologists in Canada treated boys with undescended testicles (cryptorchidism) before official guidelines were established in 2014. Researchers reviewed records of 488 patients and found that 83% were treated by urologists and 17% by surgeons. They discovered that pediatric surgeons were more likely to order pre-surgery ultrasounds (25.3% vs. 3.7%), and they had different surgical methods; for example, urologists favored a scrotal approach for palpable testicles, while surgeons preferred an inguinal approach (98.8%). Who this helps: This research helps doctors improve their treatment approaches for boys with undescended testicles.

Plain English
This study looked at how conversations about genetic testing for breast and ovarian cancer impact children aged 12 to 24 from families who have undergone BRCA testing. The researchers found that while almost all children recalled these discussions and saw them as important, their understanding of the implications was unclear, leading to mixed feelings about their own health (82% had positive feelings, while 59% felt some worries). Overall, most children were aware of the condition, felt resilient, and planned to adopt healthier lifestyles, but some expressed concerns that could be addressed with better information about genetic health. Who this helps: This benefits families affected by hereditary breast and ovarian cancer by improving children's understanding and emotional coping strategies.

Plain English
This paper looks at idiopathic pulmonary fibrosis (IPF), a serious lung disease that causes progressive scarring and can lead to early death. It highlights how two existing drugs, pirfenidone and nintedanib, slow down lung function decline but emphasizes the need for new treatments since there is currently no cure. The research also explores new therapies and support strategies that could help improve patients’ symptoms and overall quality of life. Who this helps: This helps patients with IPF and their doctors.

Plain English
This study looked at the outcomes of a type of surgery that saves the testicle while removing tumors in children with Leydig cell tumors, a rare form of testicular cancer. Out of 66 children with testicular tumors, only 9 had Leydig cell tumors, and all of them did well after surgery; none experienced a recurrence of the disease after an average follow-up of almost 32 months. This matters because it shows that doctors can often remove these tumors without needing to remove the entire testicle, which is important for the child's future health and fertility. Who this helps: This helps pediatric patients with testicular tumors and their families.

Plain English
This study looked at the use of antifibrotic drugs, specifically pirfenidone and nintedanib, in patients with a type of lung disease called fibrosing non-idiopathic pulmonary fibrosis (non-IPF) who continued to have worsening symptoms despite treatment with traditional therapies. Out of 11 patients analyzed, their lung function (measured by FVC) showed a slight improvement from 44% before starting antifibrotics to 46.5% after six months. This finding is important because it suggests that antifibrotic treatment may help some patients with progressive forms of these lung diseases when other therapies don’t work. Who this helps: This helps patients with progressive fibrosing non-IPF interstitial lung diseases.